HD18 for Advanced Stages in Hodgkins Lymphoma

NCT00515554 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Hodgkins Lymphoma

Interventions

DRUG: Rituximab
DRUG: BEACOPP escalated

Sponsor

University of Cologne